Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Baylor College of Medicine
Baylor College of Medicine
Orca Biosystems, Inc.
Shenzhen TargetRx, Inc.